Insider Transactions in Q2 2021 at Cyclacel Pharmaceuticals, Inc. (CYCC)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
Karin L Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,561
+32.5%
|
-
|
|
Jun 15
2021
|
Brian Schwartz Interim Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,561
+32.5%
|
-
|
|
Jun 15
2021
|
Christopher S Henney Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,374
+50.0%
|
-
|
|
Jun 15
2021
|
Robert J. Spiegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,374
+50.0%
|
-
|
|
Jun 15
2021
|
Sam L Barker Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,374
+49.87%
|
-
|
|
Jun 15
2021
|
Lloyd Sems Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,374
+50.0%
|
-
|
|
Jun 15
2021
|
Gregory T. Hradsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,374
+50.0%
|
-
|